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INTRODUCTION
With an estimated population of 5.58 million according
to 2006 official Nigerian census, the landmass of
Ibadan makes it the largest city in South-Western
Nigeria but the third largest metropolitan city1. The
University College Hospital, Ibadan, is the largest
teaching hospital in Nigeria, a major referral Centre,
and Federal Government designated Centre of
Excellence in the Neurological sciences2. The Eye clinic,
receives a large number of walk-in patients and
secondary referrals. Subspecialty consultation clinics,
like the Neuroophthalmology clinic, were established
in September 2007.
An unpublished review of the first 27 months in the
neuroophthalmology unit revealed optic neuropathy
as the commonest presentation. Though, optic
neuropathy is not a diagnosis in itself, as it results from
various aetiologies3, some cases of optic neuropathy
are amenable to treatment with good visual outcome4,5.
Optic neuropathy is a significant cause of visual
impairment among Nigerians6. A study in the Low
Vision Clinic in Ibadan showed that the third
commonest condition among 193 patients attending
over a 3-year period was optic atrophy7. Retinitis
pigmentosa (16%) and albinism (13.2%) especially
among children, were the commonest conditions
associated with optic atrophy in these cases 7.
Compressive optic neuropathy is a preventable and
treatable cause of visual loss and this was identified as
the commonest cause of optic atrophy in a
retrospective review of 100 randomly selected cases,
by Oluleye et al.8. Aetiology of  optic atrophy could
not be identified in 62% of patients, in the review in
question8. On the other hand, in Port Harcourt, in a
review of  99 patients with NGON, 40% of  patient
had optic atrophy at presentation9. Majority of the
patients in the Port Harcourt study were presumed to
have nutritional amblyopia (31.3%) or demyelinating
optic neuritis (27.3%) although 41.4% were
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ABSTRACT
Background: Optic neuropathy is not a diagnosis in itself, as potential
aetiologies are myriad. A pilot study conducted in the Eye Clinic,
University College Hospital, Ibadan, between September 2007 and
November 2009, showed that 46.8% of new cases presenting to the
neuroophthalmology unit, had non-glaucomatous optic neuropathy
(NGON) in which, the precise aetiology of optic neuropathy was never
diagnosed.
Methods: All cases of NGON, seen in the neuro-ophthalmology unit,
between September 2007 and June 2014 were analyzed to determine
common aetiologies and identify the difficulties encountered in their
investigation or management.
Results: There were 159 cases of NGON. The age range was 6 months to
87 years (mean 39.0, SD 21.3). Male: Female ratio was 1.2: 1, and the
commonest diagnosis was optic atrophy of  unknown aetiology.
Challenges identified included difficulty obtaining recommended
radiological and serological investigations, as well as no access to genetic
studies and high loss to follow-up.
Conclusion: There are major constraints in the investigation of patients
presenting with optic nerve disease in Ibadan, despite the prevalence of
NGON as a major cause of visual disability among neuro-ophthalmic
patients in this setting. Diagnostic constraints must be addressed, to
facilitate neuroophthalmology patient care, within our limited resources.
Key words: Optic atrophy, Non-glaucomatous optic neuropathy, Neuroophthalmology, Aetiology, Healthcare
funding, National health insurance
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undiagnosed9.  Likewise, in many patients, in the neuro-
ophthalmology clinic in Ibadan, determining the cause
of  NGON is challenging. Nevertheless, good
management of such patients must involve early
diagnosis and targeted therapy, where possible.
The objective of  this study therefore was to determine
the pattern of non-glaucomatous optic neuropathies
presenting to the neuroophthalmology unit at the Eye
clinic, University College Hospital, Ibadan and to
perform a needs analysis to identify and recommend
potential strategies for improving diagnostic patient
evaluation and outcome of care.
MATERIALS AND METHODS
The study was a retrospective analysis of all patients
diagnosed with NGON in the neuroophthalmology
unit of the eye clinic, University College Hospital,
Ibadan between September 2007 and June 2014.
During this period, a total of 17,707 patients were
seen at the eye clinic, of which 2,900 received
neuroophthalmology consultations. Diagnosis of  optic
neuropathy was based on evidence of visual
impairment on Snellen visual acuity, which was not
improved by refraction or pinhole testing, afferent
pupillary defect on pupillary examination and
ophthalmoscopic finding of diffuse or sectoral optic
disc pallor, cupping or swelling following posterior
pole examination, by means of  binocular indirect
ophthalmoscopy, using a 20D double aspheric,
antireflective coated lens, with a fully dilated pupil, and
stereoscopic disc examination using a 78D aspheric
lens at the slit lamp. Optic neuropathy was further
confirmed by demonstrating more than two faults
(mistakes) during testing of either eye, using the Ishihara
pseudochromatic plates. Cases of  glaucoma were
excluded using records of the intraocular pressure
measurements and central visual field analyses in the
case files.
Non-glaucomatous optic neuropathy (NGON) was defined
as clinical evidence of  impaired optic nerve function
in the absence of field or disc changes of glaucoma.
Aetiological groupings were determined based on
documentary evidence from case notes that identified
a clear aetiology of  optic nerve dysfunction from
clinical examination, ancillary investigations or
neuroimaging10. For instance, optic neuropathy was
categorized as compressive when there was evidence
of  optic nerve compression from an orbital or
intracranial lesion. Papilloedema was defined as optic
neuropathy associated with disc swelling and other
evidence of raised intracranial pressure.
Four hundred and forty cases of  NGON were
identified from the clinical registers. Of  these, 159 case
notes were successfully retrieved from the Records
Department. Information retrieved from these case
notes included: biodata, source of referral, presenting
history, presenting visual acuity, clinical assessment and
suspected aetiology, investigations performed,
including neuroimaging and perimetry. Patients’
compliance with performance of  requested
investigations, reasons for defaulting, management/
treatment given, visual outcome and follow-up data
were also retrieved. The information was entered and
analyzed in a spreadsheet (MS-Excel 2007).
RESULTS
Approximately 2,900 patients received neuroophthal-
mology consultations during the study period, of
which 440 cases were diagnosed with NGON
constituting 15.2% of  all neuroophthal-mology clinic
patients. A total of  159 NGON case records were
reviewed.
The age range was 6 months to 87 years. The mean
age was 39.0 years (SD 12.3 years). The modal age
group was 41 to 50 years. There were 85 (54.4%) males
and 72 (45.6%) females (M:F ratio = 1.2:1). Majority
(56%) had unilateral involvement while 44% of cases,
were bilateral.
The commonest presenting complaint was progressive
painless deterioration of vision. The average duration
of  symptoms at the time of  presentation was 9 months.
Headache was a presenting complaint in only 3.1% of
cases.
Presenting visual acuity, in the better eye, was < 6/60
in 53.6% of  cases. The cause of  NGON was identified
in only 40.9% (74/159) of  cases. Aetiology remained
undetermined in 59.1% (95/159) of  the cases. Figure
1 summarizes the pattern of aetiological presentation
among cases of  NGON.
Only 35% of patients in whom static automated
perimetry of the central 30o of the visual field (CVF
30-2) was ordered, actually performed the test.
Majority (90.5%) of  those who performed static
automated perimetry (CVF 30-2) demonstrated field
defects. Confrontation test was done in patients with
severely depressed fields and defects were detected in
all cases. Only 10% of  cases in whom neuroimaging
was requested, actually performed the test. The
commonest neuroimaging performed was cranial CT
scan. 62.5% of cases that had neuroimaging done had
detectable abnormalities. Commonest barrier to
obtaining neuroimaging was high cost and most
patients could not afford to repeat the test even when
requested. Longest duration before CT scan requested
could be done was 6 months. Some cases never had
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Ibadan 2005 Port Harcourt 2011 Ibadan 2014
Sample size 100 99 159
Study period 6 years 5 years 7 years
M:F 2:1 1.1:1 1.2:1





Conclusion Aetiology of optic
atrophy could not
be satisfactorily




Note: However, all cases of
temporal pallor (~ 31%) were
defined as nutritional optic
neuropathy and were not
specifically investigated or
confirmed as such. If this is
taken into account, then 71%
of optic neuropathies in this
study were truly undiagnosed.
Aetiology of optic
neuropathy was not
found in 59% of
cases
Table 1: Table comparing key findings in recent Nigerian studies on aetiology of  optic neuropathy
Figure 1: Pie chart showing proportions of different causes of non-glaucomatous optic neuropathy in Ibadan.
                                                   Annals of Ibadan Postgraduate Medicine. Vol. 12 No. 2 December, 2014           105
CT scan in spite of request. There was a high rate of
defaulting, 92.5% were lost to follow-up; 60.4% of
whom, defaulted after their second clinic visit follow-
up periods ranged from 1 week to six months.
DISCUSSION
This review demonstrates that finding the cause of
NGON presents a major challenge to the
ophthalmologist in the Nigerian environment; aetiology
in more than half  of  patients, remain undetermined.
Of the known aetiologies, compressive optic
neuropathy was the commonest cause of optic
neuropathy seen. The commonest cause of
compression was intracranial mass lesion in the sellar/
parasellar region. Although, this may not have been
truly representative of  the commonest aetiology,
considering the large proportion of cases with
undertermined aetiology (59.1%). The burden of  non-
glaucomatous optic neuropathy in Nigeria is high,
reaching a prevalence of 3.7% among patients with
VA <3/606. Furthermore, optic atrophy was found
in almost 1 in 4 patients (11.9%) among children
attending the Low vision clinic of UCH in a 3-year
period.7 Though the causes of optic atrophy were not
stated in both studies, it is evident that infectious
disorders like onchocerciasis, which was a major cause
of  optic neuropathy about 30 years ago, no longer
feature prominently.6, 11 Recent studies point to the
increasing significance of neuroophthalmic disorders
such as cranio-orbital tumours8, optic neuritis9, cerebral
palsy12 and hydrocephalus13 as common aetiologies seen
in the hospital setting. It is not certain, however, whether
disorders like nutritional amblyopia still abound.11, 14
Comparing the observations in this study to two similar
studies done in recent times8, 9, this study comprises
the largest review to date, of cases of NGON in
Nigeria as shown in Table 1. Furthermore, compari-
sons in table 1, highlight differences in the study date,
duration, patient demographics and the conclusions
drawn from each of  the studies. The common
challenges encountered in the management of patients
include: late presentation with severe visual disability,
unreliable patient history, high cost or lack of
diagnostic/ancillary investigations (e.g. serology,
electrophysiology, genetic) thereby forcing
ophthalmologists to perform selective testing either
based on ease of  accessibility, patient’s convenience or
patient’s willingness to pay for their tests. Patient’s must
pay out of pocket for all drugs and investigations and
are often unwilling to pay for an expensive test that
does not guarantee visual recovery, even if  it adds to
knowledge or the elucidation of their condition. In
the absence of institutional support for costly testing
such as waivers, rebates and other concessions, patient
compliance is poor.
Occasionally, detailed explanation and counseling may
encourage the patient to comply with recommended
testing however, there is a subtle conflict of interest
when one is aware of the opportunity cost to the
patient, and their financial circumstances. Patient loss
to follow-up remains high as a result of multiple
factors, chief of which remains financial constraint. A
constant feature in many of the case notes was a
reference to financial incapacity as a cause of delay or
non-compliance. This has been identified as a major
constraint in the management of many ophthalmic
conditions.15, 16 It is also possible that lack of  appropriate
rehabilitation facilities for specific visual needs, as well
as, superstitious belief in alternative therapy are other
factors that may complicate patient management in
Ibadan. Patients in our environment, frequently report
that they had sought spiritual or local traditional healing
before, during or after seeking medical consultation.17,
18 Some of these alternative therapies are costlier than
orthodox medical care but are adhered to by the
patients because of the superfluous promises of healing
and the acknowledgement of  the patient’s religious or
cultural ideals. A recent study in a tuberculosis (TB)
control programme, in Enugu, showed that 217/221
patients, consulted between 1-6 alternative sources,
before presenting to a designated TB treatment clinic17.
The first alternative source of consultation was a
chemist or herbalist. In that study, patients spent up to
US$911 and a median of US$25 on alternative
therapies17 Persistence of symptoms was the main
reason why patients abandoned alternative therapies17.
In another study, patients with mental illness
experienced a delay of up to 4.5 years before presenting
to the specialist (psychiatrist) while seeking alternative
therapy.18
In this study, it was found that patients delayed for an
average of 9 months before presenting with
symptoms to the neuroophthalmology clinic. In many
cases, they had either ignored the symptoms until they
became unbearable or attributed the visual symptoms
to a “need for spectacles”. Many patients changed
spectacles several times before seeking medical
consultation. Spectacles were often obtained from
roadside opticians and occasionally from optometrists.
However, the majority of patient referrals were from
physicians. It is noteworthy that patients often sought
non-medical consultation for their health problems.
Most patients had exhausted their material resources
before presenting to the hospital; thereby experiencing
severe constraints with their management as they faced
high cost of  virtually all health services. Individual
expenditure on healthcare in Nigeria is composed
mainly of out-of pocket-spending (OOPS) which has
been shown to be as high as 98.8% in many
households.19 The average cost of  healthcare is
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estimated at about N2219 per household per month19
with the highest burden of health expenditure falling
on the poorest individuals. Majority of  impoverished
Nigerians have traditionally relied on the government
hospitals for subsidized healthcare but the removal of
government subsidy on healthcare over the years has
led to steadily rising cost of healthcare delivery to the
individual. While it is impossible to expect healthcare
to be provided free of charge in the face of current
global practices in the healthcare system; there should
be a system in place to provide short-term support
for unexpected exponential demands that may result
from the need to obtain costly investigations such as
neuroimaging. The NHIS does not currently pay for
neuroimaging. There is a need for the National Health
Insurance Scheme to be restructured to accommodate
this reality otherwise there will continue to be an increase
in avoidable deaths and debility which will ultimately
increase the burden on the healthcare system locking it
in a vicious cycle. In addition, appropriate basic health
education must be communicated to the populace to
ensure prompt reporting of health complaints to
appropriate and skilled health personnel and institutions
to avoid unnecessary delays and out of pocket
spending. Finally, the referral structure within the
healthcare system must be established and strengthened
to promote prompt and appropriate referrals.
CONCLUSION AND RECOMMENDATIONS
In conclusion, aetiology of  NGON remains
undetermined in >50% of  patients in Ibadan. Most
patients present late, with severe visual impairment,
and face significant financial constraints hampering
investigation, diagnosis, management and follow up.
Adequate facilities for the investigation of NGON
are needed, to facilitate the diagnosis of treatable causes
such as nutritional optic neuropathy, and to preempt
avoidable conditions such as ethambutol toxicity. In
addition, a review of the National Health Insurance
Scheme is recommended, to incorporate support for
the investigation and diagnosis of major debilitating
diseases with potentially treatable outcomes, such as
diabetes and hypertension. This is because financial
incapacity often introduces delays in diagnosis,
intervention and treatment compliance, leading to an
ultimately poor outcome and a vicious cycle of distrust,
delay, disappointment, and disenfranchisement of  the
average Nigerian; who can not afford private
insurance. Furthermore, NHIS should provide cover
for neurological conditions, which are potentially
curable but carry a heavy financial burden, too heavy
for average individuals or families to bear; such as non-
malignant brain tumours. With a cost-sharing
mechanism in place, patients are enabled to present
early and receive adequate care, with good outcome.
LIMITATIONS
The main limitation of this study was the difficulty
encountered with retrieval of patient records, high
attrition rate and failure of patients to complete
recommended investigations (as described above).
Complete records of only 36.1% of cases were found.
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